INM:NASDAQ, InMed Pharmaceuticals Inc.

Why INM stock rose on November 6

InMed Pharmaceuticals Inc. rose 19.6% on Friday, November 6, 2026, on 27,154 shares, 3.6 times its average daily volume. Headlines around the move:

INM stock overview

InMed Pharmaceuticals Inc. (INM:NASDAQ) closed at $15.56 on November 6, 2026, up 19.65% on the day. The stock trades 33.2% below its 52-week high of $23.30 and 170.6% above its 52-week low of $5.75. Over the past year, it gained 29.7%. InMed Pharmaceuticals Inc. is part of the Health Care sector.

Key figures

Price
$15.56
Day change
+19.65%
Volume
27,154
Average volume
7,623
Market cap
8M+
52-week range
$5.75 – $23.30
50-day average
$13.94
200-day average
$12.20

Price action over the past year

In 252 trading sessions since November 20, 2025, INM closed higher on 96 days (38%). Its best day was May 19, 2026 (+134.95%) and its worst was November 5, 2026 (-24.51%). The stock moved 10% or more in a single session 13 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

INM news

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others.

Similar stocks

Find more stocks like INM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.